How Biden Can Stop the Bleeding on the Age Issue
Joe Biden’s age is back at the top of the political agenda. On Thursday, a special counsel report found that Biden appeared to have “significant limitations” regarding his memory. Then, at a press conference called to dispel those concerns, Biden only exacerbated them by confusing the presidents…#joebidens #egypt #mexico #donaldtrump #trump #mattbennett #thirdway #bethmyers #mittromney #democrats (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2024 Category: Consumer Health News Source Type: news
Traumatic intracranial hemorrhage in pediatrics: Implications of factor XIII deficiency and consumptive coagulopathy in abusive head trauma evaluation - L ópez AA, Cohen CT, Small A, Lam FW, Bachim AN.
For infants that present with intracranial hemorrhage in the setting of suspected abusive head trauma (AHT), the standard recommendation is to perform an evaluation for a bleeding disorder. Factor XIII (FXIII) deficiency is a rare congenital bleeding disor... (Source: SafetyLit)
Source: SafetyLit - February 9, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Rat poison threatens Italy ’s growing wolf population
Over the past few decades, Italy’s growing population of wolves has begun to edge closer to urban areas, attracted in part by tasty prey such as rats and mice. But a recent study suggests city life carries a potentially deadly risk for the predators: eating rodents tainted with poison. Analyses of more than 180 wolf carcasses found in Central and Northern Italy revealed that nearly two-thirds tested positive for rodenticides, suggesting the chemicals pose a bigger threat to wolves than previously understood.
“The results were totally unexpected,” says ecologist Jacopo Cerri of the University of Sassari, an auth...
Source: ScienceNOW - February 8, 2024 Category: Science Source Type: news
Prenatal Care Shouldn't Begin in the ED
(MedPage Today) -- "A patient just came into room five with vaginal bleeding. You should probably see her right away. She looks sick!"
I rushed to the bedside of a 33-year-old female with severe pelvic pain and vaginal bleeding. She looked ill... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - February 8, 2024 Category: OBGYN Source Type: news
RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified
Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 7, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Prytime Medical Announces Donation of $1.75 Million of Medical Aid and Training to Ukraine to Fill Gap Until Non-Lethal Medical Aid Approved by US Government
The top medical priority for the Ukrainian military in the US non-lethal aid package is Prytime Medical Device's pREBOA-PRO™ catheter because it buys time for their surgical teams to transport bleeding soldiers to safety SAN ANTONIO, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Prytime Medical... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 6, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
The Elites Opened the Doors to Migrants---and Chaos
Bleeding-heart liberalism has taken a dangerous turn toward an ideology that rejects national borders. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2024 Category: Consumer Health News Source Type: news
What is the Differential Diagnosis of a Suprarenal Mass?
Discussion
Suprarenal masses (SRM) are not that common (incidence of 1.9/1000 in neonates), but are more commonly diagnosed prenatally because of prenatal ultrasound. Masses can be difficult to accurately diagnose even after birth because their features overlap. Radiographically they can be variable in size, cystic/solid or mixed and with or without calcifications. Common signs and symptoms of SRM include anemia, jaundice, scrotal hematoma and abdominal mass. Signs of asphyxia may also occur. Often patients whose diagnosis is not clear are monitored closely for a few weeks to see how the lesion changes with time. This is e...
Source: PediatricEducation.org - February 5, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Peloton shares plummet in value as company struggles to'stop the bleeding '
Revenues are down and predicted to get worse, as indoor training company posts financial report and addresses concerns There are troubling times for the indoor training company Peloton, whose share value tumbled this week amid declining revenues. The US company, which sells static exercise bikes,…#peloton #revenues #barrymccarthy #turbo (Source: Reuters: Health)
Source: Reuters: Health - February 4, 2024 Category: Consumer Health News Source Type: news
Comparison of suture and sutureless techniques on postoperative complications after third molar surgery: a systematic review
ConclusionThe
omission of postoperative sutures in third molar surgeries appears to
favor pain and edema outcomes within the first 24 h after the procedure,
as well as trismus within the same timeframe.Clinical relevance.Despite
the suture being the standard conduct in tooth extractions. The
omission of sutures in third molar extractions may favor inflammatory
outcomes of pain, edema, and trismus in the immediate postoperative
period. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 2, 2024 Category: Dentistry Source Type: news
' Whole Blood' Transfusions Might Save More Lives
FRIDAY, Feb. 2, 2024 -- Patients who are bleeding out have a better chance of surviving if they ’re given whole blood transfusions, a new study shows.Traditionally, patients with significant bleeding are given transfusions of specific blood... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 2, 2024 Category: General Medicine Source Type: news
Genital lichen sclerosus misdiagnosis: forensic insights - Abder-Rahman H, Habash I, Hussein A, Al-Shaeb A, Elqasass A, Qaqish LN.
In this case study, we present an instance of genital lichen sclerosus et atrophicus that was initially misdiagnosed as child sexual abuse. A 6-year-old female presented to the emergency department with complaints of vaginal bleeding accompanied by pruritu... (Source: SafetyLit)
Source: SafetyLit - February 2, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
EuroTrauma, delays in access to bleeding control. A comparison between a conventional and a hybrid trauma center, both European military trauma centers - de Malleray H, Hackenberg L, Cardinale M, Kollig E, Schwab R, Bordes J, Bieler D.
PURPOSE: Comparison of access times to CT and surgical/radiological bleeding control between two European military trauma centers. METHODS: Retrospective and observational study conducted in two military level 1 trauma centers in Toulon (France) an... (Source: SafetyLit)
Source: SafetyLit - February 1, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news
New long-term data for Roche ’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry visionUp to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months apartDetailed results from two global Phase III RVO studies will be presented at Angiogenesis, Exudation, and Degeneration 2024Vabysmo is approved in the US for RVO, and in more than 90 countries around the world for people living with nAMD and DMEBasel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) i...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
